Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Follow us on Google+Follow us on TwitterFind us on LinkedInFind Us on FacebookSubscribe to our RSS FeedsSubscribe to our YouTube ChannelFind us on RebelMouse

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for January 31, 2013 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version   



Avantium Appoints Jonathan Wolfson to its Supervisory Board

Jonathan Wolfson, Chief Executive Officer and co-founder of Solazyme, joins the Supervisory Board at Avantium. His experience and insights will be very valuable for Avantium to commercialize its YXY technology.
 
x-small text small text medium text large text

    AMSTERDAM, NETHERLANDS, January 31, 2013 /24-7PressRelease/ -- Avantium announced the appointment of Jonathan Wolfson to its Supervisory Board. Jonathan Wolfson is Chief Executive Officer and co-founder of Solazyme. Solazyme is a leading industrial biotechnology company producing renewable oil and bioproducts from microalgae for fuels, chemicals, nutrition and personal care products. Solazyme (SZYM) is a US stock listed company at NASDAQ. Mr. Wolfson and Solazyme have received numerous awards for their technology pioneering role in the industrial biotechnology industry. Mr. Wolfson holds J.D. and M.B.A. degrees from the NYU School of Law and the NYU Stern School of Business.

Jonathan Wolfson said on his appointment:"I am very happy to join the Supervisory Board at Avantium. I have known the Company for years and have been increasingly impressed with its world class catalytic technology and the incredibly exciting development of the YXY technology platform. I look forward to working with the company as it brings its disruptive biobased plastics and chemicals to market."

"We are proud to have Jonathan Wolfson appointed to our Supervisory Board," says Tom van Aken, CEO of Avantium. "Jonathan has played a major role in the successful development of Solazyme, its successful IPO and the formation of strategic partnerships in the food, cosmetics and fuels industries. His experience and insights in bringing biobased chemicals to the market, will be very valuable for Avantium to commercialize its YXY technology for the production and use of FDCA and PEF."

About Avantium

Avantium is a game-changing renewable chemicals company with leadership in advanced catalysis R&D. It developed the breakthrough YXY technology, a proprietary process to convert carbohydrates into the green building blocks FDCA for making biobased plastics and biobased chemicals at cost competitive prices in large markets. Avantium's lead application PEF (polyethylene furanoate) fulfils key criteria to become the next generation biobased plastics for bottles, film and fibers. Avantium has demonstrated the value and commercial potential of its unique technology by collaborating with leading companies like The Coca-Cola Company and Danone for the development of 100% biobased PEF bottles. Avantium plans to have the first commercial scale manufacturing plant operational by 2016. Avantium laboratories and headquarters are based in Amsterdam, the Netherlands.

For more information

Please contact Mariette Hoogendoorn at +31 20 586 8010 or visit our website www.avantium.com.



---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Read more Press Releases from Dominique Levant:


Contact Information:
Dominique Levant
Avantium

Amsterdam
The Netherlands
Voice: +31205868080
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.